66歳男性。化学療法不応性の急性型成人T細胞性白血病に対し,fludarabine, busulfan, 全身放射線照射による骨髄非破壊的前処置で非血縁者間同種骨髄移植を施行した。Day12に多剤耐性緑膿菌による肺炎・敗血症を呈し,薬剤感受性検査の結果,本邦の静注用抗緑膿菌抗生剤すべてに耐性を示した。そこで,Breakpoint-checkerboard (BC) plate法による多剤併用感受性試験を行い効果が期待された,meropenem hydrateとcolistinの併用療法を開始した。治療開始後より臨床症状・検査所見ともに改善を認め,好中球の生着と共に軽快した。造血幹細胞移植患者における多剤耐性緑膿菌感染症はしばしば致死的であり,治療に難渋する。BC plate法を用いて早期に有効な薬剤を選択し,多剤耐性緑膿菌感染症を克服した一例を報告する。
A 66-year-old male with acute type adult T-cell leukemia that was refractory to chemotherapy underwent unrelated allogeneic bone marrow transplantation after non-myeloablative conditioning with fludarabine, busulfan and total body irradiation. During an episode of neutropenia on day 12 after transplantation, pneumonia and sepsis due to multi-drug resistant Pseudomonas aeruginosa developed. Drug susceptibility tests demonstrated resistance to all kinds of intravenous antibiotics available for P. aeruginosa in Japan. Multi-drug susceptibility tests by the breakpoint-checkerboard plate method were then performed and combination therapy with meropenem hydrate and colistin was started based on the test results. After starting treatment, clinical symptoms and laboratory data immediately improved and engraftment of neutrophils was achieved on day 18. Infections with multi-drug-resistant P. aeruginosa are often critical for patients after hematopoietic stem cell transplantation and are difficult to control. In this paper, we report a case of severe multi-drug-resistant P. aeruginosa infection that was successfully treated by combination therapy selected using the breakpoint-checkerboard plate method.

